Spinal cord
-
Randomized Controlled Trial Multicenter Study Comparative Study
Phase 2 trial of sustained-release fampridine in chronic spinal cord injury.
Double-blind, randomized, placebo-controlled, parallel-group clinical trial. ⋯ Group I showed significant improvement in SGI, and potential benefit on spasticity. The drug was well tolerated. Group II showed more adverse events and discontinuations.